Roivant Sciences Ltd.
ROIV
Revenue
55.13M
▲26.20M▲90.57%
3 Months ChangeAssets
6.50B
▼-726.03M▼-10.05%
3 Months ChangeLiabilities
601.16M
▼-172.79M▼-22.33%
3 Months ChangeFree Cash Flow
-193.79M
▲56.54M▲22.59%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-28
Form 8-K
ID: 0001140361-24-044434
2024-09-23
Form 8-K
ID: 0001140361-24-041663
2024-09-18
Form 8-K
ID: 0001140361-24-041344
2024-09-16
Form 8-K
ID: 0001140361-24-041188
2024-09-10
Form 8-K
ID: 0001140361-24-040650
2024-09-09
Form 8-K
ID: 0001140361-24-040507
2024-08-09
Form 10-Q
ID: 0001140361-24-036642
2024-08-08
Form 8-K
ID: 0001140361-24-036281
2024-05-30
Form 8-K
ID: 0001140361-24-027994
2024-05-30
Form 8-K
ID: 0001140361-24-027986